Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -97.71% is 67% above its 5-year average of -295.62%, near the high end of its 5-year range (-622.97%–-0.58%).
57.32% above its 12-month average of -228.91%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -24.98%.
RETURN ON ASSETS (ROA)
-97.71%
RETURN ON ASSETS (ROA) AVG TTM
-228.91%
RETURN ON ASSETS (ROA) AVG 3Y
-360.64%
RETURN ON ASSETS (ROA) AVG 5Y
-295.62%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+57.32%
CURRENT VS 3Y AVG
+72.91%
CURRENT VS 5Y AVG
+66.95%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.70%
median of 713 covered companies
CURRENT VS SECTOR MEDIAN
-218.27%
vs the sector median at left
Envoy Medical, Inc.
Market Cap
$50.96M
Return on Assets (ROA)
-97.71%
TTM Avg
-228.91%
3Y Avg
-360.64%
5Y Avg
-295.62%
Market Cap
$51.36M
Return on Assets (ROA)
-49.54%
TTM Avg
-66.28%
3Y Avg
-54.88%
5Y Avg
-41.21%
Market Cap
$51.42M
Return on Assets (ROA)
-127.67%
TTM Avg
-99.17%
3Y Avg
-76.90%
5Y Avg
-71.83%
Market Cap
$50.80M
Return on Assets (ROA)
-68.60%
TTM Avg
-124.17%
3Y Avg
-83.59%
5Y Avg
-65.75%
Market Cap
$51.70M
Return on Assets (ROA)
N/A
TTM Avg
-109.69%
3Y Avg
-346.56%
5Y Avg
-277.44%
Market Cap
$51.56M
Return on Assets (ROA)
-171.51%
TTM Avg
-144.24%
3Y Avg
-112.57%
5Y Avg
-82.33%
Market Cap
$50.36M
Return on Assets (ROA)
-22.27%
TTM Avg
-102.93%
3Y Avg
-118.23%
5Y Avg
-95.88%
Market Cap
$52.05M
Return on Assets (ROA)
5.76%
TTM Avg
13.86%
3Y Avg
7.25%
5Y Avg
29.75%
Market Cap
$52.46M
Return on Assets (ROA)
-44.77%
TTM Avg
-25.55%
3Y Avg
-81.14%
5Y Avg
-76.43%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Envoy Medical, Inc. (COCH) | $50.96M | -97.71% | -228.91% | -360.64% | -295.62% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.36M | -49.54% | -66.28% | -54.88% | -41.21% |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | -127.67% | -99.17% | -76.90% | -71.83% |
| INmune Bio, Inc. (INMB)vs › | $50.80M | -68.60% | -124.17% | -83.59% | -65.75% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.70M | N/A | -109.69% | -346.56% | -277.44% |
| Clene Inc. (CLNN)vs › | $51.56M | -171.51% | -144.24% | -112.57% | -82.33% |
| Microbot Medical Inc. (MBOT)vs › | $50.36M | -22.27% | -102.93% | -118.23% | -95.88% |
| biote Corp. (BTMD)vs › | $52.05M | 5.76% | 13.86% | 7.25% | 29.75% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | -44.77% | -25.55% | -81.14% | -76.43% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.47M | -32404.78% | -23.59% | -11.80% | -9.44% |
ROA
-97.7%
ROE
-708.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -277.59% |
| 2024-12-31 | -180.23% |
| 2023-12-31 | -361.77% |
| 2022-12-31 | -622.97% |
| 2021-12-31 | -330.60% |
| 2020-12-31 | -0.58% |
